MATX (MATX)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 5/9, Altman Z 3.4.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe capital allocation efficiency of MATX presents a structural constraint, evidenced by an ROIC-WACC spread of -2.2%, indicating that the firm currently destroys value relative to its cost of equity. This negative spread persists despite a robust profitability profile characterized by a 13.3% net margin and 22.8% gross margin; however, revenue contraction at -2.3% YoY suggests top-line pressure is eroding these margins' impact on overall returns. From an earnings stability perspective, the company exhibits moderate financial distress signals with an Altman Z-Score of 3.4, positioning it in a gray zone between safety and danger, while maintaining a solid Beneish M-Score of -2.56 that points to low likelihood of earnings manipulation. The Piotroski F-Score of 5/9 reflects a mixed fundamental trajectory, lacking the momentum required for capital appreciation despite decent leverage utilization within its DuPont ROE decomposition.
Valuation metrics suggest the market is pricing in significant downside risk given the disconnect between current multiples and intrinsic value estimates. Trading at a 11.6x P/E ratio, which appears compressed relative to typical sector standards absent specific peer data, the stock trades below its calculated DCF fair value of $33. This discrepancy implies that while earnings per share may be supported by high margins, investors are heavily discounting future cash flows due to the negative return on invested capital and declining revenue trends. The market consensus appears anchored in concerns over growth sustainability rather than current profitability quality, creating a scenario where the low multiple does not necessarily reflect undervaluation but rather a premium placed on execution risk.
The synthesis of these factors reveals a high-risk/reward profile driven by conflicting signals: strong margins versus negative capital returns and shrinking revenues. The Altman Z-Score's proximity to distress thresholds combined with the widening gap between ROIC and WACC suggests that any turnaround in revenue growth will be critical for restoring value creation capabilities. Without evidence of margin expansion or leverage optimization, the current valuation discount may persist as investors demand a higher risk premium for capital destruction rather than accumulation.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 10.6% | 12.6% | 14.6% |
|---|---|---|---|
| 2% | $39 | $31 | $25 |
| 3% | $43 | $33 | $27 |
| 4% | $48 | $36 | $29 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=12.6%, terminal growth 3%. Fair value $33 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XTN or SLYV, the fund manager is mechanically forced to buy or sell MATX shares regardless of MATX's individual fundamentals. We estimate $270M of passive capital is structurally linked to MATX through 8 tracked ETFs. Passive flows have a limited but growing influence on MATX's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in MATX to visualize passive redemption contagion across ETFs and collateral stocks.
If MATX (MATX) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies RXO INC (RXO) as the most exposed collateral stock, sharing 3 ETFs with MATX. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 9 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
MATX Ownership Dynamics
ETFs with Highest MATX Exposure
Float lock-up computed from 10 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
MATX Capital Efficiency
How efficiently does MATX convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
MATX converts 18% of its EBITDA into free cash flow, a low conversion rate suggesting heavy reinvestment. This may indicate a growth phase (building capacity) or structural capital intensity. The 82% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-2.2%), suggesting reinvested capital is destroying shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-14 | 1,815 | $181.72 | $329,821.8 |
| 2026-05-13 | 5,904 | $179.01 | $1.1M |
| 2026-05-06 | 130 | $187.26 | $24,343.8 |
| 2026-05-01 | 7 | $174.43 | $1,221.01 |
| 2026-04-29 | 15 | $175.51 | $2,632.65 |
| 2026-04-22 | 105 | $170.68 | $17,921.4 |
| 2026-04-20 | 627 | $176.55 | $110,696.85 |
| 2026-04-15 | 175 | $171.28 | $29,974 |
| 2026-04-09 | 30 | $172.49 | $5,174.7 |
| 2026-04-08 | 47 | $168.11 | $7,901.17 |
| 2026-04-07 | 70 | $167.10 | $11,697 |
| 2026-03-31 | 168 | $157.36 | $26,436.48 |
| 2026-03-26 | 5,057 | $164.30 | $830,865.1 |
| 2026-03-25 | 89 | $163.14 | $14,519.46 |
| 2026-03-23 | 237 | $155.07 | $36,751.59 |
| 2026-03-13 | 12,851 | $149.24 | $1.9M |
| 2026-03-12 | 1,625 | $153.94 | $250,152.5 |
| 2026-03-11 | 717 | $156.76 | $112,396.92 |
| 2026-03-09 | 919 | $152.99 | $140,597.81 |
| 2026-03-02 | 46 | $166.13 | $7,641.98 |
| 2026-02-26 | 19,395 | $170.05 | $3.3M |
| 2026-02-24 | 100 | $164.38 | $16,438 |
| 2026-02-17 | 34 | $162.18 | $5,514.12 |
| 2026-02-12 | 12 | $162.77 | $1,953.24 |
| 2026-02-06 | 502 | $159.81 | $80,224.62 |
| 2026-01-30 | 2,714 | $161.27 | $437,686.78 |
| 2026-01-26 | 141 | $158.94 | $22,410.54 |
| 2026-01-15 | 1,763 | $131.92 | $232,574.96 |
| 2026-01-14 | 543 | $130.59 | $70,910.37 |
| 2026-01-08 | 19,855 | $130.24 | $2.6M |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare MATX to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.